General Information of Drug (ID: DM2VDUE)

Drug Name
BIOD-123
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 2 [1]
Type-2 diabetes 5A11 Phase 2 [2]
Cross-matching ID
TTD ID
D07TKZ
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT01686620) A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)